Evolving the Standard of Care— A Review of Afirma …...Expo Theater 2030 Boxed lunches will be...

1
OBJECTIVES: • Discuss Afirma Genomic Sequencing Classifier’s (GSC) impact in the management of indeterminate thyroid nodules • Review initial Afirma GSC clinical experience data • Unveil the new Xpression Atlas Program sponsored by Veracyte, Inc., provider of the Afirma Thyroid FNA Analysis C841.1.1802 Giulia C. Kennedy, PhD Chief Scientific and Medical Officer Veracyte, Inc. Richard T. Kloos, MD Senior Medical Director Endocrinology Veracyte, Inc. Christian Nasr, MD Staff Endocrinologist Medical Director, Thyroid Center Cleveland Clinic SATURDAY, MARCH 17 1:00–2:00 PM Expo Theater 2030 Boxed lunches will be served. Space is limited. First come, first served. JOIN US FOR A SPECIAL PRESENTATION: Evolving the Standard of Care— A Review of Afirma GSC Experience Data and Introducing the New Xpression Atlas

Transcript of Evolving the Standard of Care— A Review of Afirma …...Expo Theater 2030 Boxed lunches will be...

Page 1: Evolving the Standard of Care— A Review of Afirma …...Expo Theater 2030 Boxed lunches will be served. Space is limited. First come, first served. JOIN US FOR A SPECIAL PRESENTATION:

OBJECTIVES:• Discuss Afirma Genomic Sequencing Classifier’s (GSC) impact in the

management of indeterminate thyroid nodules • Review initial Afirma GSC clinical experience data • Unveil the new Xpression Atlas

Program sponsored by Veracyte, Inc., provider of the Afirma Thyroid FNA Analysis

C841.1.1802

Giulia C. Kennedy, PhDChief Scientific and Medical OfficerVeracyte, Inc.

Richard T. Kloos, MDSenior Medical Director EndocrinologyVeracyte, Inc.

Christian Nasr, MD Staff Endocrinologist Medical Director, Thyroid CenterCleveland Clinic

SATURDAY, MARCH 171:00–2:00 PMExpo Theater 2030Boxed lunches will be served. Space is limited. First come, first served.

JOIN US FOR A SPECIAL PRESENTATION:Evolving the Standard of Care— A Review of Afirma GSC Experience Data andIntroducing the New Xpression Atlas